Screener
Acumen Pharmaceuticals, Inc. ABOS Q2 2026 earnings
Reported August 11, 2026 · Before market open
EPS-$0.45Miss by $0.09
EPS estimate-$0.36
Next report
Nov 11, 2026 (in 2 months)EPS estimate-$0.43
Versus estimates
Diluted EPS
FAQ
- When did Acumen Pharmaceuticals, Inc. report Q2 2026 earnings?
- Acumen Pharmaceuticals, Inc. (ABOS) reported Q2 2026 earnings on August 11, 2026 before market open.
- What were Acumen Pharmaceuticals, Inc.'s Q2 2026 revenue and EPS?
- Acumen Pharmaceuticals, Inc. reported eps of $-0.45 for Q2 2026.
- Did Acumen Pharmaceuticals, Inc. beat estimates in Q2 2026?
- EPS missed the consensus estimate of $-0.36 by $0.09.
- How did Acumen Pharmaceuticals, Inc.'s Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 33.8% from $-0.68.
- Where can I find Acumen Pharmaceuticals, Inc.'s Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001628280-26-055940) and the 10-Q periodic report (0001628280-26-056199) directly on SEC EDGAR. The filing index links above go to sec.gov.
